ABSTRACT
OBJECTIVE To develop a methodology for case selection and whole-exome sequencing (WES) analysis in infertile women due to recurrent oocyte maturation defects(OOMD) and/or preimplantation embryo lethality (PREMBL).
DESIGN Retrospective cohort study.
SETTING IVF patients attending the Istanbul Memorial Hospital (2015-2021). WES and bioinformatics were performed at Igenomix and National Research Council, Italy.
PATIENTS A statistical methodology for identification of infertile endophenotypes (recurrent low oocyte maturation rate, LMR, low fertilization rate, LFR, and preimplantation developmental arrest, PDA, was developed using a large IVF dataset (11,221 couples). 28 OOMD/PREMBL infertile women were subsequently enrolled for WES.
INTERVENTION 30X-WES was performed on women’s gDNA. Pathogenic variants were prioritized using a custom-made bioinformatic pipeline set to minimize false positive discoveries through resampling in control cohorts (i.e., HGDP and 1,343 WES from oocyte donors). Individual scRNAseq data from 18 human MII oocytes and antral granulosa cells(AGC) was used for genome-wide validation.
MAIN OUTCOME MEASURE Identification of High-impact variants causative of OOMD/PREMBL endophenotypes.
RESULTS Variant prioritization analysis identified 265 unique variants in 248 genes (average per sample 22.4). 87.8% of genes harbouring high-impact variants are expressed by MII oocytes and/or AGC, significantly higher compared to a random sample of controls. Seven of the 28 women (25%) are homozygous carriers of missense pathogenic variants in known candidate genes for OOMD/PREMBL, including PATL2, NLRP5 (N=2), TLE6,PADI6, TUBB8 and TRIP13. Furthermore, novel gene-disease associations were identified. One LMR woman was a homozygous carrier of high impact variants in ELSA, an essential gene for phopase I meiotic transition in mice, whereas three women carried biallelic pathogenic variants in CEP128 gene, participating in the formation of the spindle in mitosis and ciliogenesis.
CONCLUSIONS This analytical framework revealed known and new genes associated with isolated recurrent OOMD/PREMBL, providing essential indications for scaling this strategy to larger studies.
Competing Interest Statement
A.C., S.C., M.P., L.G. and M.F. are full-time employees at Igenomix. A.A., M.L.G., E.R.H., S.K., M.C., B.Y., V.C., G.D. and S.B. have no conflict. C.S. is the head of the scientific board of Igenomix.
Funding Statement
The study was supported by Igenomix, Istanbul Memorial Hospital., P.O.R. Campania FSE 2014-2020 to V.C.; A.A. and E.R.H. were supported by ERC grant 724718-ReCAP, NNF grant NNF15OC0016662, and DNRF Center grant X.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The study was approved by Memorial Sisli Hospital Ethics Committee (IRB number 2019-006).
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
↵# co-senior authors of the manuscript.
CAPSULE Standardized case selection and WES bioinformatic analysis can help the discovery of genetic variants associated with recurrent infertile phenotypes, identifying the causes of idiopathic infertility characterized by specific IVF patterns.
Data Availability
All data produced in the present study are available upon reasonable request to the authors
